EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

ROS-Responsive Diselenide-Bridged Dendritic Mesoporous Silica Nanoparticles Enhance Licochalcone D Delivery for Atopic Dermatitis Therapy Associated with Oxidative Stress Modulation and JAK2/STAT5 Inhibition

Hua Liu, Qingsong Ma, Huiping Fan, Dong Zhang, Weiyuan Ma

International Journal of Nanomedicine · 2026-11 · Volume 21 · 1-28

DOI: 10.2147/ijn.s639904 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2026-11. Verfasst von Hua Liu und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Liu, H., Ma, Q., Fan, H., Zhang, D., & Ma, W. (2026). ROS-Responsive Diselenide-Bridged Dendritic Mesoporous Silica Nanoparticles Enhance Licochalcone D Delivery for Atopic Dermatitis Therapy Associated with Oxidative Stress Modulation and JAK2/STAT5 Inhibition. International Journal of Nanomedicine, Volume 21, 1-28. https://doi.org/10.2147/ijn.s639904

Vancouver

Liu H, Ma Q, Fan H, Zhang D, Ma W. ROS-Responsive Diselenide-Bridged Dendritic Mesoporous Silica Nanoparticles Enhance Licochalcone D Delivery for Atopic Dermatitis Therapy Associated with Oxidative Stress Modulation and JAK2/STAT5 Inhibition. International Journal of Nanomedicine. 2026;Volume 21:1-28. doi:10.2147/ijn.s639904

BibTeX
@article{Liu2026,
  author = {Liu, Hua and Ma, Qingsong and Fan, Huiping and Zhang, Dong and Ma, Weiyuan},
  title = {ROS-Responsive Diselenide-Bridged Dendritic Mesoporous Silica Nanoparticles Enhance Licochalcone D Delivery for Atopic Dermatitis Therapy Associated with Oxidative Stress Modulation and JAK2/STAT5 Inhibition},
  journal = {International Journal of Nanomedicine},
  year = {2026},
  volume = {Volume 21},
  pages = {1--28},
  doi = {10.2147/ijn.s639904}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche